Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEMOLIZUMAB-ILTO for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 11 adverse event reports in the FDA FAERS database where NEMOLIZUMAB-ILTO was used for Psoriasis.

Most Reported Side Effects for NEMOLIZUMAB-ILTO

Side Effect Reports % Deaths Hosp.
Inappropriate schedule of product administration 826 19.8% 0 7
Product dose omission issue 792 18.9% 0 12
Device malfunction 761 18.2% 0 1
Incorrect dose administered 579 13.8% 0 1
Pruritus 416 10.0% 0 9
Rash 263 6.3% 1 5
Headache 181 4.3% 0 3
Drug ineffective 158 3.8% 0 2
Device leakage 153 3.7% 0 1
Device use issue 120 2.9% 0 0
Dermatitis atopic 117 2.8% 0 0
Neurodermatitis 109 2.6% 0 2
Eczema 108 2.6% 0 0
Dry skin 105 2.5% 0 1
Erythema 88 2.1% 0 5

Other Indications for NEMOLIZUMAB-ILTO

Neurodermatitis (1,765) Dermatitis atopic (1,596) Product used for unknown indication (658) Eczema (99) Pruritus (30) Dermatitis (7) Rash (5) Urticaria (5)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

NEMOLIZUMAB-ILTO Full Profile All Psoriasis Drugs NEMOLIZUMAB-ILTO Demographics NEMOLIZUMAB-ILTO Timeline